RESEARCH AND TECHNOLOGY AGREEMENTResearch and Technology Agreement • May 11th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware
Contract Type FiledMay 11th, 2001 Company Industry JurisdictionThis Research and Technology Agreement (the “Agreement”) is made effective as of January 24, 2001 (the “Effective Date”) between INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of business in Mountain View, California (hereinafter referred to as “INTRABIOTICS”), and NEW CHEMICAL ENTITIES, INC., a Delaware corporation having a principal place of business in Bothell, Washington (hereinafter referred to as “NCE”).
FIRST AMENDMENT TO THE AGREEMENT BETWEEN INTRABIOTICS PHARMACEUTICALS, INC. AND ALBANY MOLECULAR RESEARCH, INC. FIRST AMENDMENT TO THE RESEARCH AND TECHNOLOGY AGREEMENT BETWEEN INTRABIOTICS PHARMACEUTICALS, INC. AND NEW CHEMICAL ENTITIES, INC.Research and Technology Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations
Contract Type FiledAugust 14th, 2001 Company IndustryTHIS FIRST AMENDMENT TO THE RESEARCH AND TECHNOLOGY AGREEMENT is entered into as of the 13th day of April, 2001, (“Amendment Effective Date”) by and among INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation (“INTRABIOTICS”) and ALBANY MOLECULAR RESEARCH, a Delaware corporation (“AMRI”).